CASC15 Promotes Cholangiocyte Proliferation and Liver Fibrosis by Regulating the HNRNPU-IGFBP3 Axis in Biliary Atresia
Digestive Diseases and Sciences · 2026
DOI: 10.1007/s10620-026-09748-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Yao Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, 210000, Jiangsu Province, China. Hauptthemen laut MEDLINE: Biliary Atresia, Cell Proliferation, Liver Cirrhosis, Insulin-Like Growth Factor Binding Protein 3. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Postgraduate Research and Practice Innovation Program of Jiangsu Province, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
PURPOSE: Active cholangiocytes featured with massive proliferation activate hepatic stellate cells (HSCs) and could cause eventual liver fibrosis (LF), however, this crosstalk still remains unclear in biliary atresia (BA). We aimed to evaluate the involvement of cancer susceptibility candidate 15 (CASC15) in BA. METHODS: Cholangiocyte organoid culture and sequencing was used to identify differentially expressed long noncoding RNA associated with cholangiocyte proliferation. The expression level of CASC15 were detected in liver tissues. The CCK-8, EdU assay, co-culture experiments, and subcellular fractionation were employed to investigate its function and subcellular localization. Chromatin isolation by RNA purification coupled with mass spectrometry, RNA immunoprecipitation, and RNA sequencing were utilized to clarify the underlying mechanism of CASC15. RESULTS: CASC15 showed increased expression in cholangiocyte organoids and liver tissues of BA patients. Overexpressed CASC15 in cholangiocytes enhanced cell proliferation and promoted HSC activation in vitro. CASC15 predominantly located in the nucleus and was identified to interact with heterogeneous nuclear ribonucleoprotein U (HNRNPU) to maintain the expression of downstream target insulin-like growth factor binding protein 3 (IGFBP3), which could facilitate in the activation of HSCs. CONCLUSION: This research revealed the crucial role of CASC15/HNRNPU-IGFBP3 regulatory network in the pathogenesis of LF in BA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, 210000, Jiangsu Province, China.
- Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, 210000, Jiangsu Province, China. xiehua3955@126.com.
- Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, 210000, Jiangsu Province, China. twbcn@163.com.
Förderung
- Postgraduate Research and Practice Innovation Program of Jiangsu Province
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Lu, Y., Zhu, Z., Zhu, Y., Zhu, W., Zhang, R., Ding, Z., Xie, H., & Tang, W. (2026). CASC15 Promotes Cholangiocyte Proliferation and Liver Fibrosis by Regulating the HNRNPU-IGFBP3 Axis in Biliary Atresia. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-09748-2
Vancouver
Lu Y, Zhu Z, Zhu Y, Zhu W, Zhang R, Ding Z, et al. CASC15 Promotes Cholangiocyte Proliferation and Liver Fibrosis by Regulating the HNRNPU-IGFBP3 Axis in Biliary Atresia. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-09748-2
BibTeX
@article{Lu2026,
author = {Lu, Yao and Zhu, Zhongxian and Zhu, Yufei and Zhu, Wei and Zhang, Ruyi and Ding, Zequan and Xie, Hua and Tang, Weibing},
title = {CASC15 Promotes Cholangiocyte Proliferation and Liver Fibrosis by Regulating the HNRNPU-IGFBP3 Axis in Biliary Atresia},
journal = {Digestive Diseases and Sciences},
year = {2026},
doi = {10.1007/s10620-026-09748-2}
}
EUVIMED